SS
CAMP icon

SBI Securities’s CAMP4 Therapeutics CAMP Stock Holding History

SBI Securities’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44 Hold
10
– – ﹤0.01% 3699
2026
Q1 		$44 Hold
10
– – ﹤0.01% 3601
2025
Q4 		$61 Sell
10
-5
-33% -$21 ﹤0.01% 3538
2025
Q3 		$45 Sell
15
-5
-25% -$9 ﹤0.01% 3748
2025
Q2 		$29 Buy
+20
New +$40 ﹤0.01% 3835

Other funds holding CAMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SBI Securities's CAMP Position: Q2 2026 in Review

SBI Securities held its CAMP4 Therapeutics (CAMP) position steady in Q2 2026 at 10 shares worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

SBI Securities first reported a position in CAMP in Q2 2025 and has held it in 5 quarters since. The position peaked at $61 in Q4 2025. 16 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • SBI Securities held 10 shares of CAMP4 Therapeutics worth $44 as of Q2 2026.
  • SBI Securities left its CAMP4 Therapeutics share count unchanged in Q2 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3699 holding.
  • SBI Securities first reported a position in CAMP4 Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • SBI Securities's CAMP4 Therapeutics position peaked at $61 in Q4 2025.
  • 16 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.